ANDIndenture • November 25th, 2003 • Valeant Pharmaceuticals International • Pharmaceutical preparations • New York
Contract Type FiledNovember 25th, 2003 Company Industry Jurisdiction
Exhibit 10.26 VALEANT PHARMACEUTICALS INTERNATIONAL $200,000,000 3.0% CONVERTIBLE SUBORDINATED NOTES DUE 2010 $200,000,000 4.0% CONVERTIBLE SUBORDINATED NOTES DUE 2013 REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 25th, 2003 • Valeant Pharmaceuticals International • Pharmaceutical preparations • New York
Contract Type FiledNovember 25th, 2003 Company Industry Jurisdiction